nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—SCN5A—Riluzole—amyotrophic lateral sclerosis	0.637	0.812	CbGbCtD
Carbamazepine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.148	0.188	CbGbCtD
Carbamazepine—Hyperacusis—Riluzole—amyotrophic lateral sclerosis	0.00513	0.0241	CcSEcCtD
Carbamazepine—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.00484	0.0227	CcSEcCtD
Carbamazepine—CNS depression NOS—Riluzole—amyotrophic lateral sclerosis	0.00466	0.0219	CcSEcCtD
Carbamazepine—Thrombocytopenic purpura—Riluzole—amyotrophic lateral sclerosis	0.00408	0.0191	CcSEcCtD
Carbamazepine—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.00341	0.016	CcSEcCtD
Carbamazepine—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.00341	0.016	CcSEcCtD
Carbamazepine—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00341	0.016	CcSEcCtD
Carbamazepine—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0158	CcSEcCtD
Carbamazepine—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00325	0.0153	CcSEcCtD
Carbamazepine—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00318	0.0149	CcSEcCtD
Carbamazepine—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00298	0.014	CcSEcCtD
Carbamazepine—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00273	0.0128	CcSEcCtD
Carbamazepine—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.0027	0.0127	CcSEcCtD
Carbamazepine—Mania—Riluzole—amyotrophic lateral sclerosis	0.00263	0.0123	CcSEcCtD
Carbamazepine—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00256	0.012	CcSEcCtD
Carbamazepine—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.00254	0.0119	CcSEcCtD
Carbamazepine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00254	0.0119	CcSEcCtD
Carbamazepine—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.00254	0.0119	CcSEcCtD
Carbamazepine—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00248	0.0116	CcSEcCtD
Carbamazepine—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00236	0.0111	CcSEcCtD
Carbamazepine—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00232	0.0109	CcSEcCtD
Carbamazepine—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0108	CcSEcCtD
Carbamazepine—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00216	0.0101	CcSEcCtD
Carbamazepine—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00993	CcSEcCtD
Carbamazepine—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00209	0.0098	CcSEcCtD
Carbamazepine—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00974	CcSEcCtD
Carbamazepine—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00955	CcSEcCtD
Carbamazepine—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00949	CcSEcCtD
Carbamazepine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00914	CcSEcCtD
Carbamazepine—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00897	CcSEcCtD
Carbamazepine—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00897	CcSEcCtD
Carbamazepine—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00866	CcSEcCtD
Carbamazepine—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00182	0.00852	CcSEcCtD
Carbamazepine—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00842	CcSEcCtD
Carbamazepine—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00824	CcSEcCtD
Carbamazepine—Coma—Riluzole—amyotrophic lateral sclerosis	0.00175	0.0082	CcSEcCtD
Carbamazepine—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00799	CcSEcCtD
Carbamazepine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00787	CcSEcCtD
Carbamazepine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00779	CcSEcCtD
Carbamazepine—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00763	CcSEcCtD
Carbamazepine—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00763	CcSEcCtD
Carbamazepine—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00749	CcSEcCtD
Carbamazepine—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00742	CcSEcCtD
Carbamazepine—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00728	CcSEcCtD
Carbamazepine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00728	CcSEcCtD
Carbamazepine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00718	CcSEcCtD
Carbamazepine—Injury—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00709	CcSEcCtD
Carbamazepine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00693	CcSEcCtD
Carbamazepine—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0069	CcSEcCtD
Carbamazepine—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00676	CcSEcCtD
Carbamazepine—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00667	CcSEcCtD
Carbamazepine—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00654	CcSEcCtD
Carbamazepine—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00651	CcSEcCtD
Carbamazepine—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00651	CcSEcCtD
Carbamazepine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00636	CcSEcCtD
Carbamazepine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00619	CcSEcCtD
Carbamazepine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00619	CcSEcCtD
Carbamazepine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00612	CcSEcCtD
Carbamazepine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00601	CcSEcCtD
Carbamazepine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00595	CcSEcCtD
Carbamazepine—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00593	CcSEcCtD
Carbamazepine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00574	CcSEcCtD
Carbamazepine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00563	CcSEcCtD
Carbamazepine—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00552	CcSEcCtD
Carbamazepine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00541	CcSEcCtD
Carbamazepine—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0054	CcSEcCtD
Carbamazepine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00535	CcSEcCtD
Carbamazepine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00111	0.0052	CcSEcCtD
Carbamazepine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00518	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00514	CcSEcCtD
Carbamazepine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00512	CcSEcCtD
Carbamazepine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00505	CcSEcCtD
Carbamazepine—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00502	CcSEcCtD
Carbamazepine—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00502	CcSEcCtD
Carbamazepine—Depression—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00501	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00492	CcSEcCtD
Carbamazepine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00489	CcSEcCtD
Carbamazepine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00489	CcSEcCtD
Carbamazepine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00488	CcSEcCtD
Carbamazepine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00479	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00475	CcSEcCtD
Carbamazepine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.001	0.00471	CcSEcCtD
Carbamazepine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.000998	0.00468	CcSEcCtD
Carbamazepine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000977	0.00459	CcSEcCtD
Carbamazepine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000963	0.00452	CcSEcCtD
Carbamazepine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00096	0.00451	CcSEcCtD
Carbamazepine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000955	0.00448	CcSEcCtD
Carbamazepine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000953	0.00447	CcSEcCtD
Carbamazepine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000948	0.00445	CcSEcCtD
Carbamazepine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000946	0.00444	CcSEcCtD
Carbamazepine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000943	0.00443	CcSEcCtD
Carbamazepine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000941	0.00442	CcSEcCtD
Carbamazepine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000908	0.00426	CcSEcCtD
Carbamazepine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000897	0.00421	CcSEcCtD
Carbamazepine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000891	0.00418	CcSEcCtD
Carbamazepine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000871	0.00409	CcSEcCtD
Carbamazepine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000867	0.00407	CcSEcCtD
Carbamazepine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000865	0.00406	CcSEcCtD
Carbamazepine—Chills—Riluzole—amyotrophic lateral sclerosis	0.000861	0.00404	CcSEcCtD
Carbamazepine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000858	0.00403	CcSEcCtD
Carbamazepine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000848	0.00398	CcSEcCtD
Carbamazepine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00395	CcSEcCtD
Carbamazepine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000836	0.00392	CcSEcCtD
Carbamazepine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00082	0.00385	CcSEcCtD
Carbamazepine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000818	0.00384	CcSEcCtD
Carbamazepine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000812	0.00381	CcSEcCtD
Carbamazepine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000808	0.00379	CcSEcCtD
Carbamazepine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000804	0.00377	CcSEcCtD
Carbamazepine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000783	0.00368	CcSEcCtD
Carbamazepine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000772	0.00363	CcSEcCtD
Carbamazepine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000768	0.0036	CcSEcCtD
Carbamazepine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000764	0.00358	CcSEcCtD
Carbamazepine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000751	0.00352	CcSEcCtD
Carbamazepine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00075	0.00352	CcSEcCtD
Carbamazepine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000748	0.00351	CcSEcCtD
Carbamazepine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000735	0.00345	CcSEcCtD
Carbamazepine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000724	0.0034	CcSEcCtD
Carbamazepine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000722	0.00339	CcSEcCtD
Carbamazepine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000712	0.00334	CcSEcCtD
Carbamazepine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000712	0.00334	CcSEcCtD
Carbamazepine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000712	0.00334	CcSEcCtD
Carbamazepine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000709	0.00333	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000707	0.00332	CcSEcCtD
Carbamazepine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000696	0.00327	CcSEcCtD
Carbamazepine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000688	0.00323	CcSEcCtD
Carbamazepine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000682	0.0032	CcSEcCtD
Carbamazepine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000682	0.0032	CcSEcCtD
Carbamazepine—Infection—Riluzole—amyotrophic lateral sclerosis	0.000678	0.00318	CcSEcCtD
Carbamazepine—Shock—Riluzole—amyotrophic lateral sclerosis	0.000671	0.00315	CcSEcCtD
Carbamazepine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000669	0.00314	CcSEcCtD
Carbamazepine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000668	0.00313	CcSEcCtD
Carbamazepine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000666	0.00312	CcSEcCtD
Carbamazepine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000663	0.00311	CcSEcCtD
Carbamazepine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000659	0.00309	CcSEcCtD
Carbamazepine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00065	0.00305	CcSEcCtD
Carbamazepine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000637	0.00299	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000621	0.00292	CcSEcCtD
Carbamazepine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000617	0.0029	CcSEcCtD
Carbamazepine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000612	0.00287	CcSEcCtD
Carbamazepine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000608	0.00285	CcSEcCtD
Carbamazepine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000606	0.00285	CcSEcCtD
Carbamazepine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.0006	0.00282	CcSEcCtD
Carbamazepine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000593	0.00278	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000589	0.00276	CcSEcCtD
Carbamazepine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000588	0.00276	CcSEcCtD
Carbamazepine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000583	0.00274	CcSEcCtD
Carbamazepine—Pain—Riluzole—amyotrophic lateral sclerosis	0.000583	0.00274	CcSEcCtD
Carbamazepine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000562	0.00264	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000558	0.00262	CcSEcCtD
Carbamazepine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000542	0.00254	CcSEcCtD
Carbamazepine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000539	0.00253	CcSEcCtD
Carbamazepine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000539	0.00253	CcSEcCtD
Carbamazepine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000503	0.00236	CcSEcCtD
Carbamazepine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000489	0.0023	CcSEcCtD
Carbamazepine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000483	0.00226	CcSEcCtD
Carbamazepine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000467	0.00219	CcSEcCtD
Carbamazepine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000451	0.00212	CcSEcCtD
Carbamazepine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000434	0.00204	CcSEcCtD
Carbamazepine—Nepafenac—PTGS2—amyotrophic lateral sclerosis	0.000432	0.275	CrCbGaD
Carbamazepine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00043	0.00202	CcSEcCtD
Carbamazepine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00043	0.00202	CcSEcCtD
Carbamazepine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000427	0.00201	CcSEcCtD
Carbamazepine—Magnesium salicylate—PTGS2—amyotrophic lateral sclerosis	0.000423	0.269	CrCbGaD
Carbamazepine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000405	0.0019	CcSEcCtD
Carbamazepine—Salsalate—PTGS2—amyotrophic lateral sclerosis	0.000359	0.228	CrCbGaD
Carbamazepine—Oxaprozin—PTGS2—amyotrophic lateral sclerosis	0.000359	0.228	CrCbGaD
